AMANDA WILSON: Open Payments
NPI 1467826776 · CHEEKTOWAGA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,677 in 122 payments from 29 companies in 2025. Trend: 2023 $2,729 · 2024 $2,898 · 2025 $2,677
Food & beverage: $2,677
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $313 |
| Novo Nordisk Inc | 16 | $293 |
| ALK-Abello, Inc | 7 | $262 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $215 |
| Exact Sciences Corporation | 10 | $192 |
| ABBVIE INC. | 10 | $183 |
| Lilly USA, LLC | 10 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $110 |
| Axsome Therapeutics, Inc. | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
Products named: AIRSUPRA, Odactra, XIFAXAN, VRAYLAR, Ozempic, The Cologuard Plus Collection Kit, CAPLYTA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
